<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03410771</url>
  </required_header>
  <id_info>
    <org_study_id>mp05488</org_study_id>
    <nct_id>NCT03410771</nct_id>
  </id_info>
  <brief_title>Bioelectrical Impedance Analysis as a Bedside Tool to Estimate Volume of Distribution of Hydrophilic Antimicrobials in Critically Ill Patients</brief_title>
  <official_title>Bioelectrical Impedance Analysis as a Bedside Tool to Estimate Volume of Distribution of Hydrophilic Antimicrobials in Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bioelectrical impedance analysis is studied as a bedside tool to estimate capillary leak in
      order to guide dosing of hydrophilic antimicrobials.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Abstract Background: Recent data suggest that antimicrobial pharmacokinetics (PK) like volume
      of distribution (Vd) or drug clearance (CL) is extremely altered in critically ill patients
      with sepsis or septic shock due to pathophysiological alterations (e.g. influence on fluid
      status). Bioelectrical impedance analysis (BIA) was recently introduced as a simple,
      non-invasive, bedside technique to assess hydration status. The primary aim of the present
      study was to explore the correlation between BIA parameters and Vd of hydrophilic
      antimicrobial agents in critically ill patients. Furthermore, the relationship between BIA
      measurements and clinical observations was evaluated.

      Methods: We performed a validation study in healthy volunteers in September 2015 that
      confirmed the reproducibility of BIA. Subsequently, a prospective observational study was
      carried out in eligible patients treat-ed with amoxicillin/clavulanic acid, meropenem,
      piperacillin/tazobactam or vancomycin, admitted at the in-tensive care unit (ICU) of the
      University Hospitals Leuven from October 2015 to March 2016. BIA measurement was performed on
      the same day as the collection of blood samples to calculate PK parameters of the
      administered antibiotic.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2015</start_date>
  <completion_date type="Actual">June 1, 2016</completion_date>
  <primary_completion_date type="Actual">March 31, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between BIA parameters and Vd of hydrophilic antimicrobial agents</measure>
    <time_frame>6-12 hours (= dosing interval) depending on the antimicrobial studied</time_frame>
    <description>Extracellular water (ECW), intracellular water, total body water (TBW), all expressed in liter, and ECW expressed as % of TBW will be correlated with Vd (L/kg) of vancomycin, meropenem, amoxicillin/clavulanic acid and piperacillin/tazobactam</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation between BIA assessed hydration status and clinical observations</measure>
    <time_frame>1 day</time_frame>
    <description>Hydration status measured by BIA (dehydrated, normohydrated, hyperhydrated) will be correlated with SOFA score and cumulative fluid balance (L)</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">68</enrollment>
  <condition>Electric Impedance</condition>
  <condition>Pharmacokinetics</condition>
  <condition>Capillary Leak Syndrome</condition>
  <arm_group>
    <arm_group_label>ICU patients on amoxicillin/clavulanic acid</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ICU patients on piperacillin/tazobactam</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ICU patients on meropenem</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ICU patients on vancomycin</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Monitor antibiotic exposure (PK profile)</intervention_name>
    <description>several plasma samples to measure drug exposure</description>
    <arm_group_label>ICU patients on amoxicillin/clavulanic acid</arm_group_label>
    <arm_group_label>ICU patients on piperacillin/tazobactam</arm_group_label>
    <arm_group_label>ICU patients on meropenem</arm_group_label>
    <arm_group_label>ICU patients on vancomycin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bioelectrical impedance analysis to measure body composition</intervention_name>
    <description>non invasive analysis (electrodes) to measure extra- and intracellular, and total body water.</description>
    <arm_group_label>ICU patients on amoxicillin/clavulanic acid</arm_group_label>
    <arm_group_label>ICU patients on piperacillin/tazobactam</arm_group_label>
    <arm_group_label>ICU patients on meropenem</arm_group_label>
    <arm_group_label>ICU patients on vancomycin</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to our intensive care unit
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admitted to ICU ward

          -  Treated with one of the four studied antimicrobials

        Exclusion Criteria:

          -  &lt;18 years

          -  Pregnant

          -  Do Not Resuscitate code 2 or 3

          -  Renal replacement therapy

          -  ECMO

          -  Pacemaker/defibrillator

          -  Extended burns or dermatological ilness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabel Spriet, PharmD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UZLeuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Jones SL, Tanaka A, Eastwood GM, Young H, Peck L, Bellomo R, Mårtensson J. Bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation. Crit Care. 2015 Aug 12;19:290. doi: 10.1186/s13054-015-1009-3.</citation>
    <PMID>26260579</PMID>
  </reference>
  <reference>
    <citation>Balik M, Sedivy J, Waldauf P, Kolar M, Smejkalova V, Pachl J. Can bioimpedance determine the volume of distribution of antibiotics in sepsis? Anaesth Intensive Care. 2005 Jun;33(3):345-50.</citation>
    <PMID>15973917</PMID>
  </reference>
  <reference>
    <citation>Malbrain ML, Huygh J, Dabrowski W, De Waele JJ, Staelens A, Wauters J. The use of bio-electrical impedance analysis (BIA) to guide fluid management, resuscitation and deresuscitation in critically ill patients: a bench-to-bedside review. Anaesthesiol Intensive Ther. 2014 Nov-Dec;46(5):381-91. doi: 10.5603/AIT.2014.0061. Review.</citation>
    <PMID>25432557</PMID>
  </reference>
  <reference>
    <citation>Dewitte A, Carles P, Joannès-Boyau O, Fleureau C, Roze H, Combe C, Ouattara A. Bioelectrical impedance spectroscopy to estimate fluid balance in critically ill patients. J Clin Monit Comput. 2016 Apr;30(2):227-33. doi: 10.1007/s10877-015-9706-7. Epub 2015 May 29.</citation>
    <PMID>26018457</PMID>
  </reference>
  <reference>
    <citation>Lee YH, Lee JD, Kang DR, Hong J, Lee JM. Bioelectrical impedance analysis values as markers to predict severity in critically ill patients. J Crit Care. 2017 Aug;40:103-107. doi: 10.1016/j.jcrc.2017.03.013. Epub 2017 Mar 22.</citation>
    <PMID>28380407</PMID>
  </reference>
  <reference>
    <citation>Samoni S, Vigo V, Reséndiz LI, Villa G, De Rosa S, Nalesso F, Ferrari F, Meola M, Brendolan A, Malacarne P, Forfori F, Bonato R, Donadio C, Ronco C. Impact of hyperhydration on the mortality risk in critically ill patients admitted in intensive care units: comparison between bioelectrical impedance vector analysis and cumulative fluid balance recording. Crit Care. 2016 Apr 8;20:95. doi: 10.1186/s13054-016-1269-6.</citation>
    <PMID>27060079</PMID>
  </reference>
  <reference>
    <citation>Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, Hope WW, Farkas A, Neely MN, Schentag JJ, Drusano G, Frey OR, Theuretzbacher U, Kuti JL; International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis. 2014 Jun;14(6):498-509. doi: 10.1016/S1473-3099(14)70036-2. Epub 2014 Apr 24. Review.</citation>
    <PMID>24768475</PMID>
  </reference>
  <reference>
    <citation>Basso F, Berdin G, Virzì GM, Mason G, Piccinni P, Day S, Cruz DN, Wjewodzka M, Giuliani A, Brendolan A, Ronco C. Fluid management in the intensive care unit: bioelectrical impedance vector analysis as a tool to assess hydration status and optimal fluid balance in critically ill patients. Blood Purif. 2013;36(3-4):192-9. doi: 10.1159/000356366. Epub 2013 Dec 20.</citation>
    <PMID>24496190</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2018</study_first_submitted>
  <study_first_submitted_qc>January 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2018</study_first_posted>
  <last_update_submitted>January 26, 2018</last_update_submitted>
  <last_update_submitted_qc>January 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>Matthias Gijsen</investigator_full_name>
    <investigator_title>PharmD PhD researcher - Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Distribution Volume</keyword>
  <keyword>Antibiotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Capillary Leak Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
    <mesh_term>Anti-Infective Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>To be determined</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

